Ren Xing, Hu Rong, Zhang Hui
Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
Institute of Science, Technology and Humanities, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
Postgrad Med J. 2025 Jul 22;101(1198):704-715. doi: 10.1093/postmj/qgae132.
In this study, we performed a two-sample Mendelian randomization (MR) analysis to assess the causality between inflammatory cytokines and the risk of digestive tract cancers (DTCs). Furthermore, we conducted a molecular docking study to predict the therapeutic mechanisms of traditional Chinese medicine (TCM) compounds in the treatment of DTCs.
In our MR analysis, genetic variations associated with eight types of DTCs were utilized, which were sourced from a large publicly available genome-wide association study dataset (7929 cases and 1 742 407 controls of European ancestry) and inflammatory cytokines data from a genome-wide association study summary of 8293 European participants. Inverse-variance weighted method, MR-Egger, and weighted median were performed to analyze and strengthen the final results. We investigated the effects of 41 inflammatory molecules on 8 types of DTCs. Subsequently, the effect of DTCs on positive inflammatory factors was analyzed by means of inverse MR. Molecular docking was exploited to predict therapeutic targets with TCM compounds.
Interleukin-7, interleukin-16, macrophage colony-stimulating factor, monokine induced by interferon-gamma, and vascular endothelial growth factor may be significantly associated with various types of DTCs. Five TCM compounds (baicalin, berberine, curcumin, emodin, and salidroside) demonstrated better binding energies to both interleukin-7 and vascular endothelial growth factor than carboplatin.
This study provides strong evidence to support the potential causality of some inflammatory cytokines on DTCs and indicates the potential molecular mechanism of TCM compounds in the treatment of DTCs. Key message What is already known on this topic The increasing evidence indicates that inflammatory cytokines are implicated in the pathogenesis of digestive tract cancers (DTCs). Nevertheless, the causal relationship between inflammatory cytokines and DTCs remains indistinct. Additionally, certain traditional Chinese medicine compounds have been demonstrated to treat DTCs by influencing inflammatory factors, yet their underlying potential mechanisms remain ambiguous. What this study adds In this study, Mendelian randomization analysis was performed for the first time regarding the causality between human inflammatory cytokines and eight types of DTCs, which revealed that inflammatory factors may play different roles in different types of DTCs. Moreover, molecular docking of key inflammatory factors was implemented, indicating the targets for drug actions. How this study might affect research, practice, or policy This research has the potential to reveal the causality between 41 inflammatory factors and 8 DTCs, offering novel perspectives for the prevention and management strategies of DTCs. Additionally, it indicates the targets for the actions of traditional Chinese medicine on the key inflammatory factors of these cancers.
在本研究中,我们进行了两样本孟德尔随机化(MR)分析,以评估炎症细胞因子与消化道癌症(DTCs)风险之间的因果关系。此外,我们进行了分子对接研究,以预测中药化合物治疗DTCs的作用机制。
在我们的MR分析中,利用了与8种类型DTCs相关的基因变异,这些变异来自一个大型公开可用的全基因组关联研究数据集(7929例欧洲血统病例和1742407例对照)以及来自8293名欧洲参与者的全基因组关联研究汇总的炎症细胞因子数据。采用逆方差加权法、MR-Egger法和加权中位数法进行分析并强化最终结果。我们研究了41种炎症分子对8种类型DTCs的影响。随后,通过逆MR分析DTCs对阳性炎症因子的影响。利用分子对接预测中药化合物的治疗靶点。
白细胞介素-7、白细胞介素-16、巨噬细胞集落刺激因子、γ干扰素诱导的单核因子和血管内皮生长因子可能与各种类型的DTCs显著相关。五种中药化合物(黄芩苷、小檗碱、姜黄素、大黄素和红景天苷)与白细胞介素-7和血管内皮生长因子的结合能均优于卡铂。
本研究提供了有力证据支持某些炎症细胞因子与DTCs之间的潜在因果关系,并指出了中药化合物治疗DTCs的潜在分子机制。关键信息 关于该主题已有的知识 越来越多的证据表明炎症细胞因子与消化道癌症(DTCs)的发病机制有关。然而,炎症细胞因子与DTCs之间的因果关系仍不明确。此外,某些中药化合物已被证明可通过影响炎症因子来治疗DTCs,但其潜在机制仍不明确。本研究的补充内容 在本研究中,首次对人类炎症细胞因子与8种类型DTCs之间的因果关系进行了孟德尔随机化分析,结果显示炎症因子在不同类型的DTCs中可能发挥不同作用。此外,对关键炎症因子进行了分子对接,确定了药物作用靶点。本研究可能对研究、实践或政策产生的影响 本研究有可能揭示41种炎症因子与8种DTCs之间的因果关系为DTCs的预防和管理策略提供新的视角。此外,它还指出了中药对这些癌症关键炎症因子的作用靶点。